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Abstract In this study, we have investigated the expression of
the prolactin receptor gene in ovine endometrium during oestrus
cycle and pregnancy. Using reverse transcription-PCR analysis,
we provided evidence that the prolactin receptor gene is
specifically transcribed in this tissue. As shown by Northern
blot analysis, the level of the prolactin receptor transcripts
increased dramatically during late pregnancy. In situ hybridiza-
tion experiments revealed that prolactin receptor mRNA was
specifically expressed in the glandular compartment and
confirmed the dramatic increase of its expression that occurs
at the end of pregnancy. Taken together, these findings are
consistent with a putative role of prolactin and/or related
molecules in the regulation of the proliferation of the glandular
compartment and/or in the control of the secretory activity of the
endometrium.
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1. Introduction
Prolactin (PRL) is a pleitropic hormone involved in a large
number of physiological actions that can be divided into the
following categories: water and electrolyte balance, growth
and development, endocrinology and metabolism, brain and
behavior, reproduction and immunoregulation and protection
[1]. The e¡ects of PRL are mediated through an interaction
with a speci¢c high a⁄nity cell surface receptor. The presence
of prolactin receptor (PRL-R) has been detected in numerous
organs including uterus. Indeed, PRL-R gene expression has
been demonstrated in human endometrium [2,3] as well as in
rat [4,5], rabbit [6], pig [7] and bovine uterus [8]. In the uterine
tissues, PRL and its related hormones are believed to be in-
volved in the establishment and maintenance of an appropri-
ate environment for embryonic and fetal development. The
e¡ects of PRL on uterine endometrium have been particularly
studied in pig [7] and rabbit [9]. In this latter species, PRL has
been involved in hypertrophy and glandular di¡erentiation
[10] and in the alteration of uterine secretions [11,12]. More
recently, inactivation of the mouse PRL-R gene provided evi-
dence of the critical role of PRL in the implantation and
embryonic development [13]. However, the precise role of
PRL on the regulation of the uterine environment remains
to be determined.
Although the presence of the PRL-R in ovine uterus has
been previously described [6], the target tissues of PRL and/or
placental lactogen have not been determined. To further
understand the putative role of PRL and/or placental lactogen
on the uterus during pregnancy, we report experiments dem-
onstrating the transcription of the PRL-R gene in the ovine
endometrium during oestrus cycle and pregnancy. Moreover,
the cellular localization of PRL-R mRNA in the endometrium
has been undertaken by in situ hybridization.
2. Material and methods
2.1. Animals
Procedures relating to the care and use of animals were approved
by the French Ministry of Agriculture according to the French regu-
lations for animal experimentation (guideline 19/04/1988). Primipar-
ous ewes of the PreŁalpes du Sud breed were used. Oestrus cycles were
synchronized as previously described [14]. At various days of preg-
nancy and lactation, animals were killed and samples of the uterus
were collected and treated for total RNA extraction and in situ hy-
bridization.
2.2. Preparation of the hybridization probes
The 324 bp fragment beginning at the A£II restriction site and
ending at a XbaI restriction site of the ovine PRL-R cDNA, kindly
provided by Dr Bignon [15], was randomly labelled using a random
primed DNA labelling kit (Boehringer Mannheim, Meylan, France).
For in situ hybridization, recombinant Bluescript SK(3) transcription
vector (Stratagene, Ozyme, Montigny-le-Bretonneux, France) contain-
ing the full length ovine PRL-R cDNA was linearized. Antisense and
sense cRNA probes were transcribed using respectively T3 or T7
RNA polymerases (Gibco BRL-Life Technologies, Eragny, France)
and [K35S]UTP (s 1000 Ci/mmol) was used as labelled ribonucleotide
triphosphate. Full length ovine PRL-R cRNA sense probe was also
synthesized and used as a control for in situ hybridization.
2.3. RNA isolation and blotting
Total RNA was prepared from each ovine endometrium by the
guanidium isothiocyanate method described by Chomczynski and
Sacchi [16] and modi¢ed by Puissant and Houdebine [17]. 20 Wg Of
the formamide-formaldehyde denaturated total RNA was fractionated
on a 1.5% agarose gel, transferred to a Zeta-probe membrane (Bio-
Rad, Ivry sur Seine, France), hybridized at 65‡C in a bu¡er contain-
ing 0.5 M sodium dihydrogenophosphate pH 7.2, 7% SDS, 1 mM
EDTA and 0.5% non-fat dry milk and washed at 65‡C in 4USSC
(1USSC: 150 mM sodium chloride, 15 mM sodium citrate, pH 7) and
0.5% SDS.
2.4. Oligonucleotides
PRL-R primers were kindly provided by Dr C. Bignon. Upstream
primer (5P-AGCCTTCTGAATGGACAGTCACCTCCTGAAAAA-
CC-3P) and downstream primer (5P-TCCTTCACTGGGAAGTCAT-
TAGGTATCTGG-3P) correspond to the nucleotide positions 58^92
and 672^701 of the ovine PRL-R cDNA sequence respectively [15].
The expected size of the PRL-R ampli¢ed fragment was 644 bp.
2.5. Reverse transcription (RT)
RT was performed on 2 Wg of total mRNA with Superscript II
(GIBCO BRL, Life Technologies SARL, Cergy Pontoise, France)
reverse transcriptase using random hexamers in a 20 Wl reaction, 1 h
at 42‡C. A negative control which contained the ¢rst strand synthesis
reagents but no RNA sample was performed.
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2.6. PCR and analysis of ampli¢cation products
One-¢fth of the ¢rst strand synthesis reaction were ampli¢ed for 30
cycles in 25 mM MgCl2, 200 WM dNTPs, 1UPCR Bu¡er (Promega,
Lyon, France), 50 pM each primer and 5 U Taq Polymerase (Prom-
ega, Lyon, France). After the initial denaturation step (94‡C for 10
min), the ampli¢cation conditions were as follows: denaturation at
94‡C for 1 min, annealing at 60‡C for 1 min and extension at 72‡C for
1 min on a Perkin Elmer Cetus gene Amp PCR system 480 (Perkin
Elmer Cetus, Saint Quentin en Yvelines, France). After ampli¢cation,
the samples were separated on a 1% agarose gel stained with ethidium
bromide, transferred on a Zeta-probe membrane (Bio-Rad, Ivry sur
Seine, France) and hybridized with an appropriate probe as subse-
quently described.
2.7. In situ hybridization
Uterine tissues from ewes at various stages of the oestrus cycle,
pregnancy and lactation were dissected and prepared for in situ hy-
bridization as previously described for mammary tissue [14]. Antisense
and sense probes were produced by using previously described ovine
PRL-R cDNA in plasmid Bluescript (Stratagene, Montigny-le-Breton-
neux, France). Cryostat sections were processed for in situ hybrid-
ization as previously described [14].
3. Results
3.1. RT-PCR analysis of PRL-R mRNA in ovine endometrium
during oestrus cycle and pregnancy
Fig. 1 represents the ethidium bromide staining of the elec-
trophoresed PRL-R PCR products. A single band identical in
size to that ampli¢ed in the control RNA (644 bp) was ob-
tained in endometrial samples of the ewes during the oestrus
cycle and at the beginning of pregnancy. No ampli¢cation was
observed when RNA was replaced by distilled water.
The same experiments were carried out with RNA extracted
from ovine endometrium and placenta during late pregnancy.
As depicted in Fig. 2, a DNA fragment of 644 bp was ampli-
¢ed in ovine endometrium and placental tissues. Subsequent
Southern blot analysis of the same gel revealed a single band
of 644 bp hybridizing with the ovine 324 bp PRL-R probe,
con¢rming that the ovine PRL-R gene is expressed in these
tissues. No ampli¢cation was observed in RNA samples from
amniotic membranes.
3.2. Northern blot analysis of the uterine PRL-R mRNA
In order to appreciate the levels of PRL-R mRNA in ovine
endometrium during pregnancy and lactation, Northern blot
analysis was performed. Ovine mammary gland and endome-
trium PRL-R transcripts both yielded hybridizing bands of
similar sizes of 10.2 and 4.5 kb. These sizes are consistent
with those previously described in ovine mammary gland
[14]. The PRL-R mRNA level in ovine endometrium at day
14 of pregnancy was too weak to allow detection by Northern
blot experiments. This level dramatically increased during the
second half of pregnancy (Fig. 3). During lactation, no PRL-
R transcripts were detected. In the placenta, PRL-R mRNA
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Fig. 1. Ampli¢cation of PRL-R mRNA by PCR in ovine endometrium during the oestrus cycle (A) and early pregnancy (B). Size of the ampli-
¢ed DNA fragment and those of the molecular size standard are given on the left and right respectively.
Fig. 2. Ampli¢cation of PRL-R mRNA by PCR in ovine endome-
trium (Endo) at day 0 (day of insemination)(P0), 15 (P15), 85 (P85)
and 110 (P110) of pregnancy and day 70 (L70) of lactation: in
amniotic membranes at day 85 of pregnancy (Amnio P85) and in
placenta (Plac) at day 85 and 110 of pregnancy. Mammary gland
(MG) was used as positive control. Lane C corresponds to a nega-
tive control which represents ampli¢cation in the absence of RNA.
Sizes of the ampli¢ed DNA fragment and those of the molecular
size standard are given on the left and right respectively.
Fig. 3. Northern blot analysis of ovine PRL-R transcripts in ovine
endometrium at day 15 (P15), 85 (P85), 110 (P110) of pregnancy
and day 70 (L70) of lactation, in placenta at day 85 (P85) and 110
(P110) of pregnancy and in the amniotic membrane. MG: mam-
mary gland. The size of the transcripts is indicated on the right
margin.
S. Cassy et al./FEBS Letters 445 (1999) 207^211208
was barely detectable at day 110 of pregnancy. On the con-
trary, PRL-R transcripts were undetectable in the amniotic
membrane.
3.3. Localization by in situ hybridization of PRL-R mRNA in
ovine endometrium
To precise the cellular localization of PRL-R mRNA syn-
thesis, in situ hybridization was performed (Fig. 4). As de-
scribed in Section 2, a 35S-labelled ovine PRL-R cRNA anti-
sense probe was used to detect speci¢c PRL-R mRNA and a
35S-labelled ovine PRL-R cRNA sense probe was used as a
negative control. The ovine placental cotyledonary compart-
ment, the luminal epithelium, the stroma and the myometrium
exhibited no signal above that observed with the sense probe
(Fig. 4, panels 7, 8). In endometrium at day 15 of pregnancy,
a weak hybridization signal was observed within the cells of
the glandular epithelium and more precisely within the deep-
est glands (Fig. 4 panels 1, 2). This signal was dramatically
up-regulated during late pregnancy as illustrated by the in situ
hybridization experiments performed on the uterus at day 90
of pregnancy (Fig. 4 panels 3^6). This increase is associated
with a dramatic hypertrophy and enlargement of the epithelial
endometrial glands.
4. Discussion
This study clearly demonstrates that PRL-R mRNA is ex-
pressed in ovine endometrium during oestrus cycle and preg-
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Fig. 4. Cellular localization of PRL-R mRNA in ovine endometrium at day 15 (panels 1, 2) and 90 (panels 3^6) of pregnancy. A section of
the endometrium at day 15 of pregnancy (panels 7,8) was hybridized with the sense probe and used as a control of speci¢city. Shown are the
bright-¢eld (right column) and the epi-illuminated (left column) photomicrographs. Bar = 50 Wm.
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nancy. Data obtained by Northern blotting show that expres-
sion of the PRL-R gene is up-regulated during late pregnancy.
The endometrial PRL-R mRNA pattern was identical to that
previously described in the mammary gland [14]: a major
transcript of 10.2 kb and a second one of 4.5 kb. Bovine
and ovine PRL-R amino acid sequences are closely related
(91.6% of identity) [8,15]. Both ovine and bovine PRL-R are
characterized by the presence of two types of mRNA encod-
ing a long and a short form of PRL-R. The alternative splic-
ing that leads to the generation of the two forms of PRL-R
seems to be the same between bovine and ovine [15]. How-
ever, the pattern of the PRL-R transcripts in the endometrium
di¡ers between bovine and ovine species. Indeed, Scott and
colleagues [8] have described two transcripts in the bovine
endometrium, a major one of 3.8 kb and a second one of
less abundance of about 4.4 kb. The transcript of 10.2 kb
present in ovine endometrium has not been detected in the
bovine species, thus suggesting that bovine and ovine tran-
scripts might result from di¡erent alternative splicing proc-
esses.
This study represents the ¢rst demonstration of the local-
ization of the PRL-R mRNA in the endometrium of rumi-
nant. Indeed, PRL-R gene is strongly expressed in the epithe-
lial cells of the endometrial glands. Although those glands
derive from the luminal epithelium, no hybridization signal
indicating the presence of PRL-R mRNA in this region was
detected. This suggests that PRL-R gene expression is speci¢c
to one type of uterine cells. Results of in situ hybridization
revealed no obvious signal in the caruncular endometrium
(non-glandular areas) which constitute the maternal part of
the cotyledon. In the same way, no hybridization of the PRL-
R antisense probe was observed in the placenta (data not
shown). However, the presence of PRL-R mRNA in ovine
placenta was established by RT-PCR at days 85 and 110 of
pregnancy. This divergence may be explained by the di¡erence
in the sensitivity of the two techniques. Indeed the presence of
the RT-PCR ampli¢ed fragment in the placenta may be the
result of a very weak expression of the PRL-R gene not de-
tectable by in situ hybridization. Nevertheless, this fragment
may also re£ect a possible contamination of the placental
tissue by RNA extracted from endometrial glands during
the dissection. The data in this report, concerning the expres-
sion and the localization of PRL-R mRNA in ovine endome-
trium are in agreement with those previously described in
rabbit [12]. In cow, it has been also suggested that the PRL-
R gene was expressed at the level of intercaruncular endome-
trium [8,18]. On the contrary, in species characterized by de-
cidualization of the maternal stroma like human and rodents,
PRL-R gene expression observed in both the stromal and
glandular compartments is mainly associated with the decid-
ual cells [3,19,20]. Taken together, these results suggest that
the role of PRL in the endometrium might be di¡erent in
nature and time course between species where decidualization
occurs or not.
The expression of the PRL gene is essentially restricted to
the glandular cells of the pituitary. However, PRL is also
synthesized by the decidualized stromal cells of the endome-
trium in human [21,22]. In ruminants, neither decidualization
of the maternal stroma nor endometrial secretion of PRL
have been described until now. However, ovine as well as
human placenta secretes a polypeptidic hormone named pla-
cental lactogen identi¢ed by its ability to bind the PRL-R [23]
and care structural and functional similarity to the pituitary
PRL [24]. Consequently, these lactogen molecules may be in-
volved in the development and maintenance of a favorable
environment for embryonic and fetal growth in the ewe, as
it has been suggested in mice by the inactivation of the PRL-
R gene [13].
The precise role of PRL in ovine endometrium during oes-
trus cycle and pregnancy has not yet been clari¢ed. However,
several e¡ects have been previously reported in other species.
Indeed, in rabbit, PRL promotes a thickening of the uterine
endometrium by stimulating proliferation of glandular epithe-
lial cells, an increase of the glandular di¡erentiation and may
also alter the cellular composition of the endometrium [10,25].
In pig, PRL might in£uence the ionic content of the uterine
environment and the secretory activity of the endometrium
[11]. The e¡ect of PRL on the secretory activity of the endo-
metrium can not be dissociated from that of oestrogens and
progesterone. Indeed, it has been established that the treat-
ment of immature rabbits by oestrogens and progesterone
induced an increase of the level of mRNA encoding uteroglo-
bine. This increase was higher when animals were additionally
treated with PRL [12]. Thus, the PRL treatment might be
involved in the enhancement of the uterine sensitivity to pro-
gesterone through an increase in progesterone receptor con-
tent [10,26]. A servomechanism explaining this process has
been described by Chilton and colleagues [9]: acting through
its receptor, PRL induces an increase in the concentration of
the progesterone receptor. In return, progesterone acting
through its own receptor promotes the expression of the
PRL-R. By this way, PRL and progesterone may act syner-
gistically to regulate the expression of progesterone-sensitive
genes like uteroglobine. In the ewe, such a phenomenon has
not been described yet. However, various elements indicate
that PRL might in£uence the proliferation and secretory ac-
tivity of the endometrial glands. The proliferation of the ovine
glandular epithelial cells of the endometrium and the hyper-
trophy of these glands during pregnancy have been previously
described by Wimsatt [27] and might be linked to the increase
in PRL-R mRNA level which occurs concomitantly. More-
over, ovine endometrium is characterized by an intense secre-
tory activity during pregnancy and it has been shown that
progesterone may in£uence the expression of two glycopro-
teins called ‘uterine milk proteins’ [28^31].
In conclusion, the present study clearly demonstrates that
the PRL-R gene is speci¢cally expressed in the ovine endome-
trium and more precisely in the endometrial glands. The level
of PRL-R mRNA strongly increases during late pregnancy.
PRL has multiple functions throughout the body including
growth and di¡erentiation and immune response [1] and it
remains di⁄cult to assign a precise role for uterine PRL. It
will therefore be of great interest to further investigate a pos-
sible role for PRL and/or related hormones acting through the
PRL-R in the establishment of an adequate uterine environ-
ment allowing the maintenance of pregnancy.
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